Nora Sundahl

1.6k citations
39 papers · 863 indexed · h-index 16
Topics
Cancer Immunotherapy and Biomarkers (14 papers)Bladder and Urothelial Cancer Treatments (11 papers)Cancer Genomics and Diagnostics (7 papers)

In The Last Decade

Nora Sundahl

37 papers receiving 854 citations

Peers

Nora Sundahl
Comparison fields: 5 of 96
  • Oncology 321
  • Pulmonary and Respiratory Medicine 275
  • Surgery 213
  • Molecular Biology 161
  • Cancer Research 139
Replace Mutlay Sayan with:
Mutlay Sayan United States
S. Villà Italy
Puneet Pareek India
Mitsue Saito Japan
Ιlias Karapantzos Greece
Ya‐Hui Yu China
Damien Thomson Australia
Ho Jung An South Korea
Xiaolin Zhu China
Frank E. Mott United States
Nora Sundahl relative to Mutlay Sayan United States Mutlay Sayan's profile →
Citations per field
00.5×1.5×1.9×
Mutlay Sayan · 1×
Citations per year

Countries citing papers authored by Nora Sundahl

Since Specialization
Citations

This map shows the geographic impact of Nora Sundahl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nora Sundahl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nora Sundahl more than expected).

Fields of papers citing papers by Nora Sundahl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nora Sundahl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nora Sundahl. The network helps show where Nora Sundahl may publish in the future.

Co-authorship network of co-authors of Nora Sundahl

This figure shows the co-authorship network connecting the top 25 collaborators of Nora Sundahl. A scholar is included among the top collaborators of Nora Sundahl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nora Sundahl. Nora Sundahl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 3
3 5
4 54
5 4
6 109
7 10
8 14
9 8
10 7
11 45
12 5
13 6
14 20
15 26
16 31
17 21
18 24
19 165
20 8

About Nora Sundahl

Nora Sundahl is a scholar working on Oncology, Cancer Research and Biological Psychiatry, having authored 39 papers that have together received 863 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (14 papers), Bladder and Urothelial Cancer Treatments (11 papers) and Cancer Genomics and Diagnostics (7 papers). The work is most often cited by research in Otorhinolaryngology (69 citations), Oncology (321 citations) and Cancer Research (139 citations). Nora Sundahl has collaborated with scholars based in Belgium, United Kingdom and Germany. Frequent co-authors include Piet Ost, Ilse M. Beck, Claude Libert, Karolien De Bosscher, Sylvie Rottey, Fréderic Duprez, Wilfried De Neve, Liève Brochez, Vibeke Krüse and Daan De Maeseneer. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and International Journal of Radiation Oncology*Biology*Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026